Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Spark Reports Progress in Hemophilia B Gene Therapy Trial
Spark Reports Progress in Hemophilia B Gene Therapy Trial
Industry
Shire’s Phase 3 Trial Will Evaluate PK-Guided Prophylaxis with ADYNOVATE®
Shire’s Phase 3 Trial Will Evaluate PK-Guided Prophylaxis with ADYNOVATE®
Industry
Spark Therapeutics Announces Initiation of Phase 1/2 Trial
Spark Therapeutics Announces Initiation of Phase 1/2 Trial
Industry
Important Statement on HAVEN 1 Clinical Trial
Important Statement on HAVEN 1 Clinical Trial
Industry
FDA Accepts New Drug Application for AbbiVie’s HCV Combination Therapy
Industry
Bioverativ an Independent Company Spun off from Biogen
Bioverativ an Independent Company Spun off from Biogen
Industry
FDA Gives Breakthrough Designation to Hemophilia Gene Therapy
FDA Gives Breakthrough Designation to Hemophilia Gene Therapy
Industry
GenVec and WU Enter Hemophilia Therapies Agreement
GenVec and WU Enter Hemophilia Therapies Agreement
Industry
FDA will Review LFB's Application for Recombinant Factor VIIa Therapy
FDA will Review LFB's Application for Recombinant Factor VIIa Therapy
Industry
Sangamo Receives FDA Approval for Hemophilia A Gene Therapy Trial
Sangamo Receives FDA Approval for Hemophilia A Gene Therapy Trial
Industry
Sangamo and Pfizer Announce First Patient Treated in Hemophilia A Gene Therapy Trial
BioMarin’s Hemophilia A Gene Therapy Trial Demonstrates Increased FVIII…
Industry
Updated: Genentech's Subcutaneous Therapy Performing Well in Study
Updated: Genentech's Subcutaneous Therapy Performing Well in Study
Industry
Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial
Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial
Industry
UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical Trial
UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical Trial
Industry
CSL Behring Presents Data on Therapeutic Potential of Idelvion®
CSL Behring Presents Data on Therapeutic Potential of Idelvion®